Cardinal Health, a drug wholesaler that also makes gloves and surgical apparel, has been shoring up its future earnings through a series of strategic acquisitions, development of its alternate care business, and promotion of its specialty drug assets. In late 2015 the company acquired Cordis, naviHealth, and Harvard Drug; it spent much of 2016 integrating them, with a 19% increase in annual revenue to show for it. The company's pharmaceutical segment endured ongoing profit pressures for generics and the loss of a major customer but lessened the blows with new drug launches and sales growth; its medical segment grew because of acquisitions. The partnerships and purchases are a way for Cardinal Health to snag a greater share of the medical products sold to hospitals, physicians, and ambulatory centers. The company was founded in 1979 and is headquartered in Dublin, Ohio.
Company Info
| CEO | George S. Barrett |
| CEO Title | Chairman & Chief Executive Officer |
| Sector | Wholesalers |
| Industry | Wholesalers: Health Care |
| HQ Location | Dublin, OH |
| Website | www.cardinalhealth.com |
| Years on Fortune 500 List | 23 |
| Employees | 37,300 |
Key Financials (Last Fiscal Year)
| Revenues ($M) | $121,546 |
| Profits ($M) | $1,427 |
| Assets ($M) | $34,122 |
| Total Stockholder Equity ($M) | $6,554 |
| Market Value — as of March 31, 2017 ($M) | $25,725 |
Profit Ratios
| Profit as % of Revenues | 1.2% |
| Profits as % of Assets | 4.2% |
| Profits as % of Stockholder Equity | 21.8% |
Earnings Per Share (Last Fiscal Year)
| Earnings Per Share ($) | 4 |
| EPS % Change (from 2015) | 19.3% |
| EPS % Change (5 year annual rate) | 9.7% |
| EPS % Change (10 year annual rate) | 6.4% |
Total Return
| Total Return to Investors (2016) | -17.7% |
| Total Return to Investors (5 year, annualized) | 14.5% |
| Total Return to Investors (10 year, annualized) | 6.4% |
